(Q38236662)

31 August 2017

A practical guide to induced pluripotent stem cell research using patient samples (English)

1 reference

31 August 2017

1 reference

5

Akihiro Umezawa

1 reference

31 August 2017

Katherine E Santostefano

1

1 reference

31 August 2017

Takashi Hamazaki

2

1 reference

31 August 2017

Nikolett M Biel

3

1 reference

31 August 2017

Shouguang Jin

4

1 reference

31 August 2017

Naohiro Terada

6

1 reference

31 August 2017

4 August 2014

1 reference

31 August 2017

Laboratory Investigation

1 reference

31 August 2017

95

1 reference

31 August 2017

1

1 reference

31 August 2017

4-13

1 reference

https://scigraph.springernature.com/pub.10.1038/labinvest.2014.104

31 August 2017

0 references

cites work

Induced pluripotent stem cells as a next-generation biomedical interface

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Opportunities and challenges of pluripotent stem cell neurodegenerative disease models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Reprogrammed cells for disease modeling and regenerative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Pluripotent stem cells in regenerative medicine: challenges and recent progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Induced pluripotent stem cells from a spinal muscular atrophy patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Stability of genomic imprinting in human induced pluripotent stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Induced pluripotent stem cells can be used to model the genomic imprinting disorder Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader-Willi syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

DNA methylation dynamics in human induced pluripotent stem cells over time

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Imprinted expression of UBE3A in non-neuronal cells from a Prader-Willi syndrome patient with an atypical deletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

What is the point of large-scale collections of human induced pluripotent stem cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Induced pluripotent stem cell lines derived from human somatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Induced pluripotent stem cells generated without viral integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Development of defective and persistent Sendai virus vector: a unique gene delivery/expression system ideal for cell reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Generation of mouse induced pluripotent stem cells without viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

A nonviral minicircle vector for deriving human iPS cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Human induced pluripotent stem cells free of vector and transgene sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Virus-free induction of pluripotency and subsequent excision of reprogramming factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Generation of induced pluripotent stem cells using recombinant proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Reprogramming of mouse and human cells to pluripotency using mature microRNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Somatic coding mutations in human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Lectin microarray analysis of pluripotent and multipotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Defining hypo-methylated regions of stem cell-specific promoters in human iPS cells derived from extra-embryonic amnions and lung fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Reprogramming of human somatic cells to pluripotency with defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Production of hepatocyte-like cells from human pluripotent stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Signaling pathways controlling pluripotency and early cell fate decisions of human induced pluripotent stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Reprogramming of the MHC-I and its regulation by NFκB in human-induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Concurrent generation of functional smooth muscle and endothelial cells via a vascular progenitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Derivation of neural crest cells from human pluripotent stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Cerebral organoids model human brain development and microcephaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Self-formation of optic cups and storable stratified neural retina from human ESCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Self-formation of functional adenohypophysis in three-dimensional culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Vascularized and functional human liver from an iPSC-derived organ bud transplant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Using stem cells to study and possibly treat type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Blastocyst complementation generates exogenic pancreas in vivo in apancreatic cloned pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

De novo-engineered transcription activator-like effector (TALE) hybrid nuclease with novel DNA binding specificity creates double-strand breaks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Targeting DNA double-strand breaks with TAL effector nucleases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Genetic engineering of human pluripotent cells using TALE nucleases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Knockout rats generated by embryo microinjection of TALENs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Targeted gene disruption in somatic zebrafish cells using engineered TALENs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

TALEN-mediated single-base-pair editing identification of an intergenic mutation upstream of BUB1B as causative of PCS (MVA) syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

A library of TAL effector nucleases spanning the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Cell-penetrating peptide-mediated delivery of TALEN proteins via bioconjugation for genome engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Bacterial delivery of TALEN proteins for human genome editing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Multiplex genome engineering using CRISPR/Cas systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

RNA-guided human genome engineering via Cas9

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

RNA-programmed genome editing in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Efficient genome editing in zebrafish using a CRISPR-Cas system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Correction of a genetic disease in mouse via use of CRISPR-Cas9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Genome-scale CRISPR-Cas9 knockout screening in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Genetic screens in human cells using the CRISPR-Cas9 system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Cas9 effector-mediated regulation of transcription and differentiation in human pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.104

Knockout mice created by TALEN-mediated gene targeting

21 January 2018

1 reference

12 December 2020

Reprogramming of human fibroblasts to pluripotent stem cells using mRNA of four transcription factors.

1 reference

12 December 2020

The tale of the TALEs

1 reference

12 December 2020

Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease

1 reference

12 December 2020

Reactivation of maternal SNORD116 cluster via SETDB1 knockdown in Prader-Willi syndrome iPSCs

1 reference

12 December 2020

Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells

1 reference

12 December 2020

Hematopoietic and endothelial differentiation of human induced pluripotent stem cells

1 reference

12 December 2020

10.1038/LABINVEST.2014.104

Identifiers

DOI

1 reference

Dimensions Publication ID

31 August 2017

0 references

1 reference